Gender Differences in Takotsubo Syndrome

Published Date: 14 Mar 2023

Takotsubo syndrome is more common in women. Less is known about its occurrence in men. This study provides a description of the disease characteristics and incidence of TTTS in men.

Read Full News

Latest News

Low-cost vaccine vial monitors damaging heat exposure brought to market

A color-changing label could help prevent millions of vaccine doses from going to waste, say scientists from the University of Surrey. The innovation, now being commercialized through a partnership with MM PACKAGING GmbH ...

Flu season has arrived—and so have updated flu vaccines

As the autumn's cool weather settles in, so does flu season—bringing with it the familiar experiences of sniffles, fever and cough.

Should we decide by lottery who gets a medical treatment first?

For decades, ethicists have argued that lotteries could be the fairest way to decide who gets life-saving treatment when there isn't enough to go around. Yet our research suggests that most people would rather leave the choice ...

Vaccine shows promise against typhoid and invasive Salmonella in first human trial

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase I clinical trial of a novel vaccine designed to protect against both ...

CDC stops recommending COVID-19 shots for all, leaves decision to patients

The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone—leaving the choice up to patients.

California partnership aided COVID-19 response and health equity, report finds

The COVID-19 pandemic did not affect everyone equally. Communities of color, especially Latino (including undocumented persons), Black, and Native American groups, as well as people with low incomes, experienced much higher ...

Todays Updates

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Todays Updates

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Latest News

A color-changing label could help prevent millions of vaccine doses from going to waste, say scientists from the University of Surrey. The innovation, now being commercialized through a partnership with MM PACKAGING GmbH ...

As the autumn's cool weather settles in, so does flu season—bringing with it the familiar experiences of sniffles, fever and cough.

For decades, ethicists have argued that lotteries could be the fairest way to decide who gets life-saving treatment when there isn't enough to go around. Yet our research suggests that most people would rather leave the choice ...

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase I clinical trial of a novel vaccine designed to protect against both ...

The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone—leaving the choice up to patients.

The COVID-19 pandemic did not affect everyone equally. Communities of color, especially Latino (including undocumented persons), Black, and Native American groups, as well as people with low incomes, experienced much higher ...

News All Time

New vaccine panel recommends doctor consults before COVID shots

A new federal vaccine panel appointed by U.S. Health Secretary Robert F. Kennedy Jr. has recommended tighter restrictions on COVID-19 shots.

CDC advisers limit MMRV combo vaccine, delay hepatitis B vote

Top vaccine advisers hand-selected by Health Secretary Robert F. Kennedy Jr. voted Thursday to limit the use of a combination shot that protects against measles, mumps, rubella and chickenpox.

West Coast states issue their own COVID, flu, RSV vaccine rules

Four Western states are taking a different approach from the U.S. Centers for Disease Control and Prevention (CDC) on vaccines for COVID-19, flu and RSV.

US vaccine panel to hold high-stakes policy meeting

A US panel stacked with figures sympathetic to the anti-vaccine movement will on Thursday take on federal immunization recommendations in a highly politicized meeting that could upend longstanding medical advice.

Vaccine death and side effects database relies on unverified reports—it's now being taken out of context

Trump officials intend to link 25 child deaths to COVID-19 vaccines, according to reporting from The Washington Post. These findings will reportedly be discussed during the Sept. 18–19, 2025, meeting of the Centers for ...

Why Florida's plan to end vaccine mandates will likely spread to other conservative states

Florida Gov. Ron DeSantis announced a plan in early September 2025 that he intends to make Florida the first state to end vaccine mandates across all schools and in other state-run institutions such as nursing homes.

LGBTQ-friendly states led US in mpox vaccination uptake, study shows

U.S. states with stronger LGBTQ+ equality laws saw significantly higher mpox vaccination rates during the 2022–2023 epidemic compared to states with weaker protections, according to a study by CUNY SPH researchers published ...

More states protect access to the COVID shot as feds restrict eligibility

At least 17 states have taken steps to ensure broader access to the COVID-19 vaccine since August, when the federal government significantly restricted eligibility for the shot.

Illinois' Cook County confirms second suburban measles case of the year, in 4-year-old child

Health officials have confirmed the second case of measles in suburban Cook County this year—in a 4-year-old, unvaccinated child.

California's summer COVID wave shows signs of waning: What are the numbers in other communities?

There are some encouraging signs that California's summer COVID wave might be leveling off.

California says it can no longer trust Washington on COVID vaccines: Is a major battle looming?

California's late summer COVID surge is showing signs of peaking, but the state's war with the Trump administration over vaccines is just beginning.

Kennedy's vaccine committee plans to vote on COVID-19, hepatitis B and chickenpox shots

Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory committee meets this week, with votes expected on whether to change recommendations on shots against COVID-19, hepatitis B and chickenpox.

One in six US parents rejecting standard vaccine schedule: Poll

One in six American parents has delayed or skipped some or all of the standard childhood vaccines, according to a new Washington Post poll released Monday.

Should physicians have to see children whose parents oppose vaccinations?

As Florida seeks to end vaccine mandates, a behind-the-scenes debate in the medical community has been thrust into the public spotlight: Should doctors see young patients whose parents do not want them to get shots?

When should I get my flu shot? Can I get COVID vaccine at the same time?

As fall approaches, it's time to start preparing for the start of flu season as well.

RFK Jr. said 'everybody can get' a COVID vaccine: Is that true?

"Everybody can get" the COVID-19 vaccine.

Recommended News For You

Prostate cancer detection with PET CT and PET MRI is comparable.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

AI tool automates liver tumor detection and monitoring

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Implant-based reconstruction linked to increased risk of breast lymphomas

Recommended Articles For You

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options  

Navigating the Complexities of Esophageal Cancer Staging 

Understanding Axitinib: What You Need To Know For Your Treatment Plan 

Polycythemia Vera: A Historical Perspective and Contemporary Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

2.

Urinary tract cancer prediction models with high sensitivity and specificity

3.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

4.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

5.

Updates from the 2022 WHO classification of kidney epithelial tumors

1.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

2.

Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA

3.

Unraveling the Genetic Mystery of Hereditary Spherocytosis

4.

The Genetics of Bernard Soulier Syndrome: What We Know so Far

5.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot